iSpecimen Corp (ISPC) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Graphic logo of iSpecimen Inc (ISPC)

iSpecimen Inc. (ISPC) has created a unique digital environment that connects global biomaterial repositories with pharmaceutical centers, generating a powerful network effect. This chart on GURU.Markets captures the EV/EBITDA ratio at 0.00, linking the ecosystem to its profit generators: fees from R&D laboratories and corporations for sample sourcing. The brand's impeccable ethical standing ensures the company remains a benchmark within the scientific community.

iSpecimen - ISPC Company Value to EBITDA (period 11/23/2025 - 11/10/2026)

Analytical breakdowns for iSpecimen Inc.

- market price and analyst price targets:
Price Chart iSpecimen|ISPC - Analyst Median Target
- market capitalization details:
Market Value ISPC|ISPC - Full Business Value
- book value of equity indicators:
Book Value per Share iSpecimen|ISPC - Total Stockholders' Equity|Market Capitalization to Book Value Ratio ispecimen.com|ISPC - Cumulative Company Assets
- debt burden and liquidity indicators:
Total Debt to Capital iSpecimen Inc.|ISPC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity iSpecimen|ISPC - Company Total Debt|Debts to Book Capitalization ISPC|ISPC - Long-Term Debt|Company Short-Term Debt iSpecimen|Quick Liquidity Indicator ispecimen.com
- financial results and valuation multiples details:
ISPC - Final Profit|Projected Future Earnings iSpecimen Inc.|ISPC - Business Payback Period|Future Price to Earnings iSpecimen|ISPC - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple ISPC|ISPC - Operating profit before deduction of amortization|Net earnings per share for the last 12 months iSpecimen|ISPC - Net earnings per share for the last four quarters|Quarterly EPS earnings growth ispecimen.com|ISPC - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year iSpecimen Inc.
Analysis of all company metrics:iSpecimen Corp ISPC
Product sample of iSpecimen

For iSpecimen Inc., which is developing a high-tech biospecimen marketplace with significant R&D expenditures, this indicator is critical for assessing business value relative to its operating profit before depreciation and amortization. By analyzing the company's EV/EBITDA history, an investor determines the real value of the business accounting for net debt, which allows them to filter out market noise and identify fundamental undervaluation or overheating of the innovative IT-med potential.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veeva Systems Inc VEEV|Total Company Value to Operating Income Before Depreciation Ratio Doximity Network (DOCS)|HQY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio WAY|CRVL: EV/EBITDA Multiple|Company Value to EBITDA Privia Health Group, Inc. (PRVA)|HURN (Huron Consulting) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Certara Software (CERT)|EV/EBITDA Multiple OMCL|Total Company Value to Operating Income Before Depreciation Ratio goodrx.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Schrödinger SDGR|PHR - Enterprise Value to EBITDA Ratio|Omada Health Corp - EV/EBITDA Multiple|Company Value to EBITDA Evolent Corp|HealthStream, Inc. (HSTM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation DH|Enterprise Value to EBITDA Ratio CCSI|AGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ABSI|Total Company Value to Operating Income Before Depreciation Ratio So-Young Corp|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization National Research NRC|SPOK: Enterprise Value to Operating Income Before Depreciation|OptimizeRx - EV/EBITDA Multiple|TruBridge Inc (TBRG) - Enterprise Value to EBITDA Ratio|SLP (Simulations Plus Corp) - Enterprise Value to EBITDA Ratio|SOPH - Total Company Value to Operating Income Before Depreciation Ratio|HCAT (Health Catalyst, Inc.) - EV/EBITDA Multiple|CareCloud Corp (CCLD) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Research Solutions, Inc. (RSSS)|Total Company Value to Operating Income Before Depreciation Ratio dlhcorp.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OneMedNet ONMD|SCNX (Scienture Corp) - Company Value to Operating Income Before Depreciation Ratio|Healthcare Triangle - EV/EBITDA Multiple|Bullfrog AI Holdings (BFRG) - Enterprise Value to EBITDA Ratio|WORX: EV/EBITDA Multiple|MSPR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ICCT|MEDS (TRxADE Health Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ORGS (Orgenesis Inc.)|RCM (r1rcm.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sharecare SHCR|STRM - Enterprise Value to EBITDA Ratio|Syra Health Corporation - EV/EBITDA Multiple|Company Value to EBITDA Apollo Medical Holdings|MODN: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation NXGN